2.10
price up icon2.44%   0.05
 
loading

Savara Inc Borsa (SVRA) Ultime notizie

pulisher
Jun 18, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Savara Inc.SVRA - Bluefield Daily Telegraph

Jun 18, 2025
pulisher
Jun 18, 2025

Insiders Who Purchased US$783.7k Of Savara Stock May Not Have Expected 12% Tumble - simplywall.st

Jun 18, 2025
pulisher
Jun 14, 2025

Savara’s SWOT analysis: biotech firm’s stock poised for growth with aPAP drug - Investing.com

Jun 14, 2025
pulisher
Jun 13, 2025

Savara Inc (NASDAQ:SVRA) Stake Reduced by California State Teachers Retirement System - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $482,000 Stock Holdings in Savara Inc (NASDAQ:SVRA) - Defense World

Jun 12, 2025
pulisher
Jun 09, 2025

Savara Inc (NASDAQ:SVRA) Shares Sold by Bank of America Corp DE - Defense World

Jun 09, 2025
pulisher
Jun 08, 2025

Ameriprise Financial Inc. Takes Position in Savara Inc (NASDAQ:SVRA) - Defense World

Jun 08, 2025
pulisher
Jun 08, 2025

Jane Street Group LLC Decreases Stock Holdings in Savara Inc (NASDAQ:SVRA) - Defense World

Jun 08, 2025
pulisher
Jun 07, 2025

savara elects board members and approves proposals at annual meeting - Investing.com Australia

Jun 07, 2025
pulisher
Jun 06, 2025

savara elects board members and approves proposals at annual meeting By Investing.com - Investing.com South Africa

Jun 06, 2025
pulisher
Jun 06, 2025

Savara Re-elects Board Members at Annual Meeting - TipRanks

Jun 06, 2025
pulisher
Jun 06, 2025

Savara Inc (NASDAQ:SVRA) Shares Bought by Squarepoint Ops LLC - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

FDA Requests Additional Data for Savara’s MOLBREEVI Application - MSN

Jun 05, 2025
pulisher
Jun 05, 2025

Savara assumed with an Outperform at Oppenheimer - MSN

Jun 05, 2025
pulisher
Jun 05, 2025

Nuveen Asset Management LLC Sells 30,766 Shares of Savara Inc (NASDAQ:SVRA) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Savara Inc. to Present at Jefferies Global Healthcare Conference on June 4, 2025 - MSN

Jun 04, 2025
pulisher
Jun 04, 2025

Millennium Management LLC Grows Stake in Savara Inc (NASDAQ:SVRA) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Savara Inc (NASDAQ:SVRA) Shares Bought by ProShare Advisors LLC - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Savara Inc.SVRA - FinancialContent

Jun 02, 2025
pulisher
Jun 02, 2025

Insider Buying Alert: Joseph Mccracken Acquires Additional Shares of Savara Inc (SVRA) - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Oppenheimer assumes Savara stock at outperform, sets $5 price target - Investing.com

Jun 02, 2025
pulisher
Jun 02, 2025

Oppenheimer assumes Savara stock at outperform, sets $5 price target By Investing.com - Investing.com Canada

Jun 02, 2025
pulisher
Jun 02, 2025

Oppenheimer Adjusts Price Target on Savara to $5 From $15, Maintains Outperform Rating - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

Oppenheimer Maintains Optimism for Savara (SVRA) Despite Filing Setback | SVRA Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Savara director Joseph McCracken buys $20,825 in stock By Investing.com - Investing.com South Africa

Jun 02, 2025
pulisher
Jun 02, 2025

Savara director Joseph McCracken buys $20,825 in stock - Investing.com Australia

Jun 02, 2025
pulisher
Jun 02, 2025

What is HC Wainwright’s Forecast for Savara FY2026 Earnings? - Defense World

Jun 02, 2025
pulisher
May 31, 2025

Savara Inc (NASDAQ:SVRA) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World

May 31, 2025
pulisher
May 31, 2025

What is HC Wainwright’s Forecast for Savara FY2029 Earnings? - Defense World

May 31, 2025
pulisher
May 31, 2025

Savara Inc. Grants Equity Awards to New Employees - MSN

May 31, 2025
pulisher
May 30, 2025

FDA Denies Langhorne-Based Savara Application for Rare Lung Disease Treatment - BUCKSCO.Today

May 30, 2025
pulisher
May 30, 2025

Did Savara Inc. (SVRA) Mislead Investors? Levi & Korsinsky Investigates - ACCESS Newswire

May 30, 2025
pulisher
May 30, 2025

Savara (NASDAQ:SVRA) Lowered to “Neutral” Rating by HC Wainwright - Defense World

May 30, 2025
pulisher
May 29, 2025

SVRA: Savara Downgraded by HC Wainwright & Co. | SVRA Stock News - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Savara stock rating cut to Neutral by H.C. Wainwright - Investing.com Nigeria

May 29, 2025
pulisher
May 29, 2025

HC Wainwright & Co. Downgrades Savara (SVRA) - MSN

May 29, 2025
pulisher
May 29, 2025

This Starbucks Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Benzinga

May 29, 2025
pulisher
May 29, 2025

HC Wainwright Downgrades Savara to Neutral From Buy, Adjusts Price Target to $2 From $6 - marketscreener.com

May 29, 2025
pulisher
May 29, 2025

H.C. Wainwright Lowers Savara (SVRA) Outlook Following FDA Setba - GuruFocus

May 29, 2025
pulisher
May 29, 2025

H.C. Wainwright Lowers Savara (SVRA) Outlook Following FDA Setback | SVRA Stock News - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Savara stock price target cut to $2 at Evercore ISI By Investing.com - Investing.com Canada

May 29, 2025
pulisher
May 29, 2025

Savara Inc (NASDAQ:SVRA) Shares Bought by D. E. Shaw & Co. Inc. - Defense World

May 29, 2025
pulisher
May 29, 2025

Guggenheim Reaffirms “Buy” Rating for Savara (NASDAQ:SVRA) - Defense World

May 29, 2025
pulisher
May 29, 2025

Savara (NASDAQ:SVRA) Given New $2.00 Price Target at Evercore ISI - Defense World

May 29, 2025
pulisher
May 29, 2025

Savara (NASDAQ:SVRA) Price Target Lowered to $7.00 at Wells Fargo & Company - Defense World

May 29, 2025
pulisher
May 29, 2025

SVRA ALERT: Levi & Korsinsky Investigates Savara Inc. on Behalf of Shareholders Who Lost Money - ACCESS Newswire

May 29, 2025
pulisher
May 28, 2025

Savara Showcases Promising Phase 3 Trial Data for Molgramostim at ATS 2025 - MSN

May 28, 2025
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Capitalizzazione:     |  Volume (24 ore):